Compare OCFC & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCFC | AXGN |
|---|---|---|
| Founded | 1902 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 1996 | N/A |
| Metric | OCFC | AXGN |
|---|---|---|
| Price | $19.35 | $33.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $21.60 | ★ $33.67 |
| AVG Volume (30 Days) | 343.7K | ★ 904.5K |
| Earning Date | 01-22-2026 | 10-29-2025 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $378,558,000.00 | $214,709,000.00 |
| Revenue This Year | N/A | $21.57 |
| Revenue Next Year | $12.51 | $15.79 |
| P/E Ratio | $14.87 | ★ N/A |
| Revenue Growth | N/A | ★ 18.72 |
| 52 Week Low | $14.29 | $9.22 |
| 52 Week High | $20.76 | $34.24 |
| Indicator | OCFC | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 61.62 | 84.09 |
| Support Level | $18.67 | $27.50 |
| Resistance Level | $19.66 | $34.24 |
| Average True Range (ATR) | 0.59 | 1.49 |
| MACD | 0.15 | 0.44 |
| Stochastic Oscillator | 86.97 | 91.28 |
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.